Volume 25, Number 7—July 2019
Historical Review
Facility-Associated Release of Polioviruses into Communities—Risks for the Posteradication Era
Figure

Figure. Reported incidents of facility-associated poliovirus release from laboratories and manufacturing sites in the pre–polio vaccine era (shown inside dashed-line frames) and the time of poliovirus vaccine introduction to the present (shown inside solid-line frames). AFP, acute flaccid paralysis; IPV, inactivated poliovirus vaccine; MEF-1, wild poliovirus type 2 laboratory reference strain; WPV, wild poliovirus; WPV3, wild poliovirus type 3.
Page created: June 17, 2019
Page updated: June 17, 2019
Page reviewed: June 17, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.